{name}
{subtitle}
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~20 mi. (Aberdeen, United Kingdom, +159 more cities)
facility
Aberdeen Royal Infirmary ( Site 0708)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~20 mi. (Aberdeen, United Kingdom, +122 more cities)
facility
Royal Infirmary Aberdeen ( Site 2403)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
city
~20 mi. (Aberdeen, United Kingdom, +127 more cities)
facility
Aberdeen Royal Infirmary ( Site 2905)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
city
~20 mi. (Aberdeen, United Kingdom, +70 more cities)
facility
Aberdeen Royal Infirmary ( Site 0911)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.
city
~20 mi. (Aberdeen, United Kingdom, +52 more cities)
facility
Investigational Site
drug
AB680, +4 more drugs
drug type
chemotherapy, +2 more types